Tursi, A., & Tiano, M. (2021). SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab. Journal of Gastrointestinal and Liver Diseases, 30(2), 310-311. https://doi.org/10.15403/jgld-3572